# Ukko: Research, Cambridge, United States

> Ukko: Ukko is a biotechnology company focused on addressing food allergies and sensitivities through innovative immunotherapies.

Source: https://millionrounds.com/startup/ukko (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Ukko

Ukko is a biotechnology company focused on addressing food allergies and sensitivities through innovative immunotherapies.

Funding reported Last round: Series B

Research Cambridge, United States

Company summary

- **Founded:** 2016 10 years old
- **Team:** 72 51 to 200 people
- **Funding reported:** $48M in dollars
- **Last round:** Series B Jan 2021

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Ukko has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Ukko

Ukko is a biotechnology company focused on addressing food allergies and sensitivities through innovative immunotherapies.

Founded in 2016 and headquartered in Tel Aviv, Israel, with an office in Palo Alto, California, Ukko combines immunology, computational biology, and protein engineering to develop treatments for individuals suffering from food allergies and gluten-related disorders. The company utilizes an advanced computational protein design platform that employs artificial intelligence and machine learning. This technology allows Ukko to create modified allergens that retrain the immune system, develop safe proteins for consumption, and design mRNA delivery systems to mitigate severe allergic reactions. Ukko's product pipeline includes investigational therapeutics for peanut allergies and improved gluten for celiac patients, with plans to expand to other major allergens. Ukko primarily serves pharmaceutical companies, food industry partners, healthcare providers, and ultimately aims to improve the quality of life for millions affected by food allergies.

## What company datasets say Ukko raised

Funding, as reported

Reported in all **$48M** in dollars

Rounds **2**

Last round **Series B**

Last round size **$8.3M**

Last round date **Jan 2021**

Investors listed **8**

## Founders and team

From Ukko's own website and the SEC filings it signed: 3 founders, 5 on the team.

**Dr. James Baker** Founding Director of

**Anat Binur** Co-Founder *Named on its 2017 Form D*

**Yanay Ofran** PhD, Chairman & Co-founder *Named on its 2017 Form D*

- **Uri Lopatin** Md, CEO
- **Jeff Rona** CFO ​ ​
- **Matt Ottmer** COO
- **Moshe Ben David** PhD, CTO
- **Prof. Stephen Dreskin** Medical Director, Allergy and Clinical Immunology

On the board, as filed i *Samir Kaul* *Scott Brady*

Advisers *Dr. Daniel Adelman*

## On 2 portfolio pages

Investors who name them

- [Khosla Ventures](https://millionrounds.com/fund/khosla-ventures)
- [Western Technology Investment](https://millionrounds.com/fund/wti)

Each firm lists Ukko on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care biopharma innovation immune system re-education biotechnology research immune system modulation computational protein design allergy treatment pipeline immunology allergen immune tolerance protein engineering hospital & health care ai-driven drug design medical therapeutic development health food allergy therapeutics

Built with from their website

Google Cloud Google Workspace Viewport Meta TrustArc Varnish webpack Google Cloud Hosting Google Meet Priority Hints React

+8 more

Microsoft Exchange Sirvoy Wix eCommerce MySQL Microsoft 365 Apps & Services WebsiteBuilder Mobile Friendly Lodash

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834, 8731
- **Region:** Massachusetts
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/ukko)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Ukko in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)